The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
Abstract
An emerging hypothesis to explain the mechanism of heroin-induced positive reinforcement states that opiates inhibit gamma-aminobutyric acid (GABA)-ergic interneurons within the mesocorticolimbic dopamine (DA) system to disinhibit DA neurons. In support of this hypothesis, we report that the development of heroin self-administration (SA) behavior in drug-naive rats and the maintenance of SA behavior in heroin-trained rats were both suppressed when the GABA(B) receptor agonist baclofen was coadministered with heroin. Microinjections of baclofen into the ventral tegmental area (VTA), but not the nucleus accumbens, decreased heroin reinforcement as indicated by a compensatory increase in SA behavior. Additionally, baclofen administered alone or along with heroin dose-dependently reduced heroin-induced DA release. This effect was blocked partially by intra-VTA infusion of the GABA(B) antagonist 2-hydroxysaclofen, suggesting an additional, perhaps GABA(A) receptor-mediated, disinhibitory effect. Taken together, these experiments, for the first time, demonstrate that heroin-reinforced SA behavior and nucleus accumbens DA release are mediated predominantly by GABA(B) receptors in the VTA and suggest that baclofen may be an effective agent in the treatment of opiate abuse.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, lesion or inactivation of the mesolimbic DA system in the VTA [137,138] or in the NAc [139-143] decreases cocaine, amphetamine, heroin, and nicotine self-administration in rats.”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [138]
Citations
Cites
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Mansour, A., Khachaturian, H., Lewis, M. E. S., Akil, H., & Watson, S. J. (1988) · Pain · doi:10.1016/0304-3959(88)90103-0 · Cited by 973
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
GABAA and GABAB receptor site distribution in the rat central nervous system
Bowery, N. G., Hudson, A. L., & Price, G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90098-4 · Cited by 867
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Two types of neurone in the rat ventral tegmental area and their synaptic inputs.
Johnson, S. W., & NORTH, R. A. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019136 · Cited by 672
Pettit, H. O., Ettenberg, A., Bloom, F. E., & Koob, G. F. (1984) · Psychopharmacology · doi:10.1007/bf00427441 · Cited by 651
Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
Ettenberg, A., Pettit, H. O., Bloom, F. E., & Koob, G. F. (1982) · Psychopharmacology · doi:10.1007/bf00428151 · Cited by 563
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539
Research works printed but not linked: 1
- Ling, 1998, Baclofen as a cocaine anti-craving medication: A preliminary clinical study., Neuropsychopharmacology, 18, 403
Cited by
Sorted by citations
Items 101–177 of 177
Ruiu, S., Longoni, R., Spina, L., Orrù, A., Cottiglia, F., Collu, M., Kasture, S. B., & Acquas, E. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835f3d15 · Cited by 31
“, 2009) as well as in motivated behaviors (Xi and Stein, 1999; Cousins et al., 2002; Leite-Morris et al., 2004; Spano et al., 2007), we assayed the affinity of WSE for these receptors.”
BackgroundMethodBrebner, K., Froestl, W., & Roberts, D. C. S. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0952-7 · Cited by 31
“…recent studies that examined the effect of GABAergic drugs on heroin self-administration showed that the gamma-transaminase inhibitor gamma-vinylgaba (GVG) and baclofen reduced heroin self-administration and heroin-induced increases in NAC DA release (Gerasimov and Dewey 1999; Xi and Stein 1999).”
BackgroundVengeliene, V., Takahashi, T. T., Драволина, О. А., Владимировна, Б. И., Zvartau, E. E., Bespalov, A., & Spanagel, R. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4893-9 · Cited by 30
Sahraei, H., Amiri, Y.-A., Haeri-Rohani, A., Sepehri, H., Salimi, S. H., Pourmotabbed, A., Ghoshooni, H., Zahirodin, A., & Zardooz, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.012 · Cited by 29
Potential roles of GABA receptors in morphine self-administration in rats
Yoon, S. S., Lee, B. H., Kim, H. S., Choi, K. H., Yun, J., Jang, E. Y., Shim, I., Kim, J., Kim, M.-R., & Yang, C. H. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.034 · Cited by 29
Role for ventral pallidal GABAergic mechanisms in the regulation of ethanol self-administration
Kemppainen, H., Raivio, N., & Kiianmaa, K. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2709-x · Cited by 28
“The inhibitory effect of GABAB receptor agonists on the self-administration of drugs of abuse is often interpreted through a modulation of dopaminergic neurotransmission on the level of the ventral tegmental area or the NAc (Cousins et al. 2002; Xi and Stein 1999; Yoon et al. 2009).”
InfluentialDopaminergic Reward Pathways and Effects of Stress
Marinelli, M. (2007) · Elsevier eBooks · doi:10.1016/b978-012370632-4/50006-1 · Cited by 30
Peng, X., Li, X., Gilbert, J. G., Pak, A. C., Ashby, C. R., Brodie, J. D., Dewey, S. L., Gardner, E. L., & Xi, Z. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.10.004 · Cited by 28
“…GABAB receptor agonists, but not GABA itself, inhibits NAc DA and glutamate (Xi and Stein, 1998, 1999; Xi et al., 2003), and similarly drug (cocaine or heroin) self-administration and reinstatement of drug-seeking behaviors (Xi and Stein, 1999; McFarland et al., 2003; Roberts Drug Alcohol Depend.”
BackgroundSelf-citationDiaz, S. L., Kemmling, A. K., & Balerio, G. N. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00102-x · Cited by 28
A GABAB agonist reverses the behavioral sensitization to morphine in rats
Bartoletti, M., Ricci, F., & Gaiardi, M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0693-8 · Cited by 28
“…that BCF decreases stimulus maintained responding for many drugs of abuse, including heroin, cocaine, d-amphetamine and nicotine (Brebner et al. 2002b, 2005; Di Ciano and Everitt 2003; Markou et al. 2004; Roberts et al. 1996; Xi and Stein 1999), but not for natural reinforcers (Shoaib et al. 1998).”
BackgroundHalbout, B., Quarta, D., Valerio, E., Heidbreder, C. A., & Hutcheson, D. M. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00278.x · Cited by 27
“…for other abused drugs such as nicotine (FR and PR schedules) (Paterson, Froestl & Markou 2005) and heroin (second order schedule and FR schedule) (Xi & Stein 1999; Di Ciano & Everitt 2003), heroin-induced reinstatement (Spano et al. 2007), morphine (FR schedule) (Yoon et al. 2007) and alcohol…”
BackgroundPaterson, N. E. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c7083 · Cited by 27
“Systemic administration of GABAB receptor agonists most likely acts at the level of the ventral tegmental area (Xi and Stein, 1999), adding to tonic GABA-ergic inhibitory control of DA cell activity (Klitenick et al.”
BackgroundGalaj, E., Manuszak, M., Arastehmanesh, D., & Ranaldi, R. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.008 · Cited by 23
“Stimulation of D1 receptors also facilitates the release of TA GABA that, through inhibitory action on DA cells, can inhibit endritic [25,34,35] and axonal release of DA [36–38].”
GABAB Receptors and Drug Addiction: Psychostimulants and Other Drugs of Abuse
Li, X., & Slesinger, P. A. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_187 · Cited by 25
GABAB receptor inhibition causes locomotor stimulation in mice
Colombo, G., Melis, S., Brunetti, G., Serra, S., Vacca, G., Carai, M. A. M., & Gessa, G. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01494-7 · Cited by 24
Dobrovitsky, V., Pimentel, P., Duarte, A., Froestl, W., Stellar, J. R., & Trzcińska, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00007-2 · Cited by 24
“Acc (Kalivas et al., 1990; Klitenick et al., 1992; Yoshida et al., 1994; Xi and Stein, 1999).”
Rajaei, Z., Alaei, H., Nasimi, A., Amini, H., & Ahmadiani, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.040 · Cited by 23
Maccioni, P., Lorrai, I., Contini, A., Leite‐Morris, K. A., & Colombo, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.012 · Cited by 21
“, 2000), heroin (Xi and Stein, 1999), and nicotine (Corrigall et al.”
Differential involvement of GABAA and GABAB receptors in propofol self-administration in rats
Yang, B., Wang, B., Lai, M., Zhang, F., Yang, X.-W., Zhou, W., & Lian, Q. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.123 · Cited by 21
Paterson, N. E., Bruijnzeel, A. W., Kenny, P. J., Wright, C., Froestl, W., & Markou, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.031 · Cited by 21
Baclofen: Therapeutic Use and Potential of the Prototypic GABAB Receptor Agonist
Bowery, N. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-46044-4_17 · Cited by 20
Orrù, A., Fujani, D., Cassina, C., Conti, M., Clemente, A. D., & Cervo, L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2672-6 · Cited by 20
Jackson, G. L., Wood, S. G., & Kuehl, D. E. (2000) · Endocrinology · doi:10.1210/endo.141.11.7754 · Cited by 20
Effect of saikosaponin A on maintenance of intravenous morphine self-administration
Yoon, S. S., Kim, H. S., Cho, H., Yun, J., Chung, E. Y., Jang, C., Kim, K. J., & Yang, C. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.075 · Cited by 19
Cedillo, L. N., & Miranda, F. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71471-3 · Cited by 18
Reversal of the sleep–wake cycle by heroin self-administration in rats
Coffey, A. A., Guan, Z., Grigson, P. S., & Fang, J. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.09.008 · Cited by 18
Blacktop, J. M., Vranjkovic, O., Mayer, M., Hoof, M. V., Baker, D. L., & Mantsch, J. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.013 · Cited by 17
“…considering that GABA receptor agonist injections into the VTA suppress dopamine release (Yoshida et al., 1994), drug self-administration (Xi and Stein, 1999, Brebner et al., 2000 and Backes and Hemby, 2008), and reinstatement (McFarland and Kalivas, 2001, Di Ciano and Everitt, 2004 and…”
BackgroundMethodMorphine dependence is attenuated by red ginseng extract and ginsenosides Rh2, Rg3, and compound K
Yayeh, T., Yun, K., Jang, S., & Oh, S. (2016) · Journal of Ginseng Research · doi:10.1016/j.jgr.2016.08.006 · Cited by 17
“Several lines of evidence show that the GABAA receptor complex is involved in the development of opioid tolerance [15]; hence, it may be a useful target for the treatment of drug abuse and dependence [34,35].”
BackgroundTargeting the GABAB Receptor for the Treatment of Substance Use Disorder
Frankowska, M., Przegaliński, E., & Filip, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-46044-4_14 · Cited by 18
Neurochemistry Underlying Relapse to Opiate Seeking Behaviour
Brown, R. M., & Lawrence, A. J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9967-y · Cited by 20
The role of GABAB receptors in depression and antidepressant‐related behavioural responses
Slattery, D. A., & Cryan, J. F. (2006) · Drug Development Research · doi:10.1002/ddr.20110 · Cited by 16
Yoon, I.-S., Kim, H.-S., Hong, J. T., Lee, M.-K., & Oh, K. (2002) · Pharmacology · doi:10.1159/000064345 · Cited by 16
Li, X., Huang, M., Yang, L., Guo, N., Yang, X., Zhang, Z., Bai, M., Ge, L., Zhou, X., Li, Y., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00309 · Cited by 15
“Similarly, activation of GABABR in the VTA by baclofen blocks both heroin self-administration behavior and DA release in the NAc (26, 27) and morphine-induced CPP (28).”
BackgroundWilkerson, J. L., Felix, J. S., Restrepo, L. F., Ansari, M. I., Coop, A., & McMahon, L. R. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255844 · Cited by 14
“Previous studies have shown that baclofen decreases the reinforcing effects of opioids in rat self-administration procedures (Xi and Stein, 1999; Ramshini et al., 2013).”
BackgroundResultEffects of saikosaponin A on cocaine self-administration in rats
Yoon, S. S., Seo, J., Ann, S. H., Kim, H. Y., Kim, H. S., Cho, H., Yun, J., Chung, E. Y., Koo, J. S., & Yang, C. H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.029 · Cited by 13
Miranda, F., Jiménez, J. C., Cedillo, L. N., Sandoval-Sánchez, A. R., Millán-Mejía, P., Sánchez-Castillo, H., & Velázquez-Martínez, D. N. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.002 · Cited by 13
“…of baclofen into the VTA reduced cocaine self-administration under fixed ratio (Shoaib et al., 1998) and progressive ratio schedules (Brebner et al., 2000b), and microinjections also reduced heroin self-administration (Xi and Stein, 1999) and D-AMPH-induced motor activity (Kalivas et al., 1990).”
Role for GABA agonists in the nucleus accumbens in regulating morphine self-administration
Yoon, S. S., Kim, J., Lee, B. H., Choi, K., Shim, I., Choi, S. H., Hwang, M., & Yang, C. H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.018 · Cited by 13
DeBaker, M. C., de Velasco, E. M. F., McCall, N. M., Lee, A. M., & Wickman, K. (2021) · eNeuro · doi:10.1523/eneuro.0081-21.2021 · Cited by 13
“, 2002, 2004) and attenuated selfadministration of cocaine, opioids, and other drugs of abuse (Xi and Stein, 1999; Brebner et al., 2000; LeiteMorris et al., 2004; Backes and Hemby, 2008).”
BackgroundBaclofen as Adjunctive Treatment for a Patient With Cocaine Dependence and Schizoaffective Disorder
Kaplan, G. B., McRoberts, R. L., & Smokler, H. J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138778.78633.45 · Cited by 12
Akuzawa, S., Irie, M., Kanki, M., Shirakawa, T., & Sato, Y. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.02.003 · Cited by 10
Topkara, B., Yananlı, H. R., Sakallı, E., & Demirkapu, M. J. (2017) · Pharmacology · doi:10.1159/000477548 · Cited by 10
Factors affecting the ability of baclofen to reduce fat intake in rats
Wojnicki, F. H. E., Brown, S. D., & Corwin, R. L. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000031 · Cited by 9
“…burst firing of dopamine neurons in the ventral tegmental area (Erhardt et al., 2002), and reduces heroin self-administration as well as heroin-induced dopamine release in the nucleus accumbens (Xi and Stein, 1999), effects that may also account for the ability of baclofen to reduce fat intake.”
BackgroundInfluentialA Brief History and the Significance of the GABAB Receptor
Vlachou, S. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_264 · Cited by 8
Bartoletti, M., Colantoni, A., Luca, V. D., & Gaiardi, M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.08.011 · Cited by 8
Solecki, W., KROWKA, T., Filip, M., & Przewłocki, R. (2005) · PubMed · Cited by 8
McFarland, K., & Kalivas, P. W. (2003) · Wiley eBooks · doi:10.1002/0471264385.wei0314 · Cited by 8
Schlussman, S. D., Buonora, M. J., Brownstein, A. J., Zhang, Y., Ho, A., & Kreek, M. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.040 · Cited by 7
“…of DA release into the NAc (Westerink et al., 1996; Xi and Stein, 1998), as well as the attenuation of heroin self-administration behaviors (Xi and Stein, 1999) and morphine-induced CPP (Tsuji et al., 1996), we have not observed any strain-related differences in GABA-B receptor subunit…”
BackgroundAlavian, F., & Ghiasvand, S. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9018 · Cited by 7
“The role of GABAB receptors in reduction of heroin (16) and cocaine (44) self-administration in rats is also well documented.”
BackgroundCan the incentive-sensitization theory of addiction incorporate addiction to opioid drugs?
Robinson, T. E., & Berridge, K. C. (2026) · Psychopharmacology · doi:10.1007/s00213-025-07001-8 · Cited by 6
“An increase in dopamine release in the NAc during heroin self-administration has also been reported using FSCV (Xi et al. 1998; Xi and Stein 1999), although there was some individual variation in the pattern of response.”
The genetic basis of individual differences in reward processing and the link to addictive behavior
Yacubian, J., & Büchel, C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.00016-9 · Cited by 7
Pachenari, N., Channell, A. L., Belilos, A. J., Dienel, S. J., & Moussawi, K. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06747-5 · Cited by 5
“Baclofen can inhibit opioid self-administration (Xi and Stein 1999), reinstatement (Spano et al. 2007), locomotor sensitization (Leite-Morris et al. 2004), and opioid-induced dopamine release (Fadda et al. 2003).”
Baclofen zur Behandlung der Alkoholabhängigkeit
Müller, C. A., Volkmar, K., Hein, J., & Heinz, A. (2010) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000032 · Cited by 5
Jackson, G. L. (2000) · Endocrinology · doi:10.1210/en.141.11.3940 · Cited by 5
“the effect of heroin on self-administrative behavior (49).”
BackgroundYoon, I.-S., Shin, I.-C., Hong, J. T., Lee, M. K., & Oh, K. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976564 · Cited by 4
GABAB Receptor ad a Potential Therapeutic Target
Bowery, N. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_12 · Cited by 3
Baclofen alters flash-evoked potentials in Long–Evans rats
Hetzler, B. E., & Ondracek, J. M. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.02.020 · Cited by 3
Neurobiology of opioid use disorder
Cucinello‐Ragland, J. A., Lintz, T., & Morón, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26504-4.00008-9 · Cited by 2
Cedillo, L. N., Ruíz-García, R. I., Jiménez, J. C., & Miranda, F. (2019) · Experimental Brain Research · doi:10.1007/s00221-019-05540-z · Cited by 2
Hermenau, M., Stamper, B., Leung, K., Pomm, R., Guerrier, C., Cammilleri, J., & Johnson, B. (2023) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1498 · Cited by 2
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-816988-9.00001-1 · Cited by 2
Gassmann, M., & Bettler, B. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn013 · Cited by 2
Baclofen and opioid interactions in mice could inform pain treatment methods
Totsch, S. K., Meir, R., Landis, A. R., Quinn, T. L., & Sorge, R. E. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2024.100531 · Cited by 1
VTA GABAergic Plasticity: An Inhibitory Synaptic Model of Drug Addiction
Nugent, F. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6978-1_5 · Cited by 1
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50003-6 · Cited by 1
Ахмадеев, А. В., & Калимуллина, Л. Б. (2019) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00756-6 · Cited by 1
Twining, R. C. (2007) · Cited by 1
Jang, S. Y., Kim, Y.-H., & Oh, S. (2002) · Neurochemical Research · doi:10.1023/a:1020399716812 · Cited by 1
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50007-6 · Cited by 1
Pharmacology of GABAB receptors
Bowery, N. G. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch12 · Cited by 1
Motivational Systems: Rewards and Incentive Value
LaLumiere, R. T., & Kalivas, P. W. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop203014
Glutamatergic mechanisms in schizophrenia : Role of endogenous kynurenic acid
Nilsson, L. K. (2005) · Figshare
Inhibitory G-protein Modulation of CNS Excitability.
Kehrl, J. H. (2014) · Deep Blue (University of Michigan)
Endogenous kynurenic acid and schizophrenia : Physiological and pharmacological aspects
Schwieler, L. (2006) · Figshare
Structure/activity relationship of alpha-conotoxins targeting GABAB receptor
Køller, K. S. (2011) · NORA - Norwegian Open Research Archives
Functional imaging of neural systems associated with alcohol reward and amphetamine toxicity
Dudek, M. (2016) · Työväentutkimus Vuosikirja
The discriminative stimulus effects of baclofen and gamma hydroxybutyrate in C57BL/6J mice
Wilkerson, J. L., Hiranita, T., Koek, W., & McMahon, L. R. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000691
“Specifically, baclofen decreased the reinforcing effects of opioids in rat self-administration procedures (Xi and Stein, 1999; Ramshini et al., 2013), and abolished morphine preference in the place conditioning assay in mice (Meng et al.”
Background
Metadata
- Authors
- Xi, Z.-X., & Stein, E. A.
- Affiliations
- Medical College of Wisconsin (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 290
- Issue
- 3
- Pages
- 1369-1374
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2164726829
- Cited by
- 177
- References
- 40
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 7
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institute on Drug Abuse (R01DA009465, DA 09465)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- baclofen, heroin self-administration, GABAB receptors, mesolimbic dopamine system, ventral tegmental area, nucleus accumbens, GABAergic interneurons, disinhibition, 2-hydroxysaclofen, GABAA receptor
- MeSH terms
- Animals, Baclofen, Behavior, Animal, Heroin, Dopamine, Electrodes, Limbic System, Male, Mesencephalon, Narcotic Antagonists, Narcotics, Nucleus Accumbens, Self Administration, Rats, Sprague-Dawley, Ventral Tegmental Area, GABA Agonists, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review